Bioresorbable Coronary Stents Market Size, Share, Trends, Growth Outlook

Bioresorbable Coronary Stents Market is estimated to increase at a growth rate of 14.8% CAGR over the forecast period from 2024 to 2030.

The Bioresorbable Coronary Stents Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Brand (Magmaris, Magnitude, MeRes-100, DESolve, Others).

An Introduction to Bioresorbable Coronary Stents Market in 2024

The Bioresorbable Coronary Stents market in 2024 represents a paradigm shift in interventional cardiology, offering a revolutionary approach to coronary artery disease treatment. Bioresorbable stents, designed to dissolve gradually after restoring blood flow, eliminate long-term complications associated with permanent metallic stents, such as restenosis and thrombosis. With growing patient demand for minimally invasive treatment options and advancements in stent technology, bioresorbable stents gain traction as a viable alternative to conventional drug-eluting stents. Regulatory approvals for innovative stent designs and bioresorbable materials drive market expansion, while clinical evidence supports their safety, efficacy, and long-term outcomes. Collaborative efforts between medical device manufacturers, cardiologists, and healthcare institutions drive innovation and adoption of bioresorbable coronary stents, paving the way for improved patient care in the field of interventional cardiology.

Bioresorbable Coronary Stents Market Trend: Growing Preference for Minimally Invasive Procedures

A prominent trend in the Bioresorbable Coronary Stents market is the growing preference for minimally invasive procedures in cardiovascular interventions. Patients and healthcare providers increasingly favor treatments that offer reduced recovery times, lower risk of complications, and improved patient outcomes. Bioresorbable coronary stents, which gradually dissolve over time, are gaining popularity as they eliminate the need for permanent metallic implants and offer potential benefits such as restoration of vessel function and reduced risk of late stent thrombosis.

Bioresorbable Coronary Stents Market Driver: Rising Incidence of Coronary Artery Disease

The primary driver for the Bioresorbable Coronary Stents market is the rising incidence of coronary artery disease (CAD) globally. CAD is a leading cause of morbidity and mortality worldwide, with millions of people affected by coronary artery blockages and related cardiovascular events such as heart attacks and strokes. As the prevalence of risk factors such as obesity, diabetes, and hypertension continues to rise, the demand for effective treatment options for CAD, including coronary stenting, is increasing. Bioresorbable coronary stents offer a promising alternative to traditional metallic stents, driving market growth as healthcare providers seek innovative solutions to address the growing burden of CAD.

Bioresorbable Coronary Stents Market Opportunity: Advancements in Stent Technology and Materials

An opportunity in the Bioresorbable Coronary Stents market lies in the continued advancements in stent technology and materials. As research and development efforts focus on enhancing the performance and biocompatibility of bioresorbable stents, there is potential for innovation in design, materials, and manufacturing processes. Opportunities exist for companies to develop bioresorbable stents with improved mechanical properties, faster degradation rates, and better endothelialization, leading to enhanced long-term outcomes for patients. By investing in research and development and collaborating with academic institutions and regulatory agencies, companies can capitalize on the growing demand for next-generation bioresorbable coronary stents and gain a competitive edge in the market.

Bioresorbable Coronary Stents Market Segmentation

By Brand
Magmaris
Magnitude
MeRes-100
DESolve
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Bioresorbable Coronary Stents Market Companies

Abbott
Arterial Remodeling Technologies SA
Biotronik
Boston Scientific Corp
Cordis
Elixir Medical
Medtronic
Meril Life Sciences Pvt. Ltd
REVA Medical LLC

 

 

Reasons to Buy the Bioresorbable Coronary Stents Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Bioresorbable Coronary Stents Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Bioresorbable Coronary Stents Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Bioresorbable Coronary Stents Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Bioresorbable Coronary Stents Market Size Outlook, $ Million, 2021 to 2030
3.2 Bioresorbable Coronary Stents Market Outlook by Type, $ Million, 2021 to 2030
3.3 Bioresorbable Coronary Stents Market Outlook by Product, $ Million, 2021 to 2030
3.4 Bioresorbable Coronary Stents Market Outlook by Application, $ Million, 2021 to 2030
3.5 Bioresorbable Coronary Stents Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Bioresorbable Coronary Stents Market Industry
4.2 Key Market Trends in Bioresorbable Coronary Stents Market Industry
4.3 Potential Opportunities in Bioresorbable Coronary Stents Market Industry
4.4 Key Challenges in Bioresorbable Coronary Stents Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Bioresorbable Coronary Stents Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Bioresorbable Coronary Stents Market Outlook By Segments
7.1 Bioresorbable Coronary Stents Market Outlook by Segments
By Brand
Magmaris
Magnitude
MeRes-100
DESolve
Others

8 North America Bioresorbable Coronary Stents Market Analysis And Outlook To 2030
8.1 Introduction to North America Bioresorbable Coronary Stents Markets in 2024
8.2 North America Bioresorbable Coronary Stents Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Bioresorbable Coronary Stents Market size Outlook by Segments, 2021-2030
By Brand
Magmaris
Magnitude
MeRes-100
DESolve
Others

9 Europe Bioresorbable Coronary Stents Market Analysis And Outlook To 2030
9.1 Introduction to Europe Bioresorbable Coronary Stents Markets in 2024
9.2 Europe Bioresorbable Coronary Stents Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Bioresorbable Coronary Stents Market Size Outlook By Segments, 2021-2030
By Brand
Magmaris
Magnitude
MeRes-100
DESolve
Others

10 Asia Pacific Bioresorbable Coronary Stents Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Bioresorbable Coronary Stents Markets in 2024
10.2 Asia Pacific Bioresorbable Coronary Stents Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Bioresorbable Coronary Stents Market size Outlook by Segments, 2021-2030
By Brand
Magmaris
Magnitude
MeRes-100
DESolve
Others

11 South America Bioresorbable Coronary Stents Market Analysis And Outlook To 2030
11.1 Introduction to South America Bioresorbable Coronary Stents Markets in 2024
11.2 South America Bioresorbable Coronary Stents Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Bioresorbable Coronary Stents Market size Outlook by Segments, 2021-2030
By Brand
Magmaris
Magnitude
MeRes-100
DESolve
Others

12 Middle East And Africa Bioresorbable Coronary Stents Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Bioresorbable Coronary Stents Markets in 2024
12.2 Middle East and Africa Bioresorbable Coronary Stents Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Bioresorbable Coronary Stents Market size Outlook by Segments, 2021-2030
By Brand
Magmaris
Magnitude
MeRes-100
DESolve
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Arterial Remodeling Technologies SA
Biotronik
Boston Scientific Corp
Cordis
Elixir Medical
Medtronic
Meril Life Sciences Pvt. Ltd
REVA Medical LLC

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Brand
Magmaris
Magnitude
MeRes-100
DESolve
Others